Clinical Trials

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT03999710 2025-11-28

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

61 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Recurrence

NCT05253807 2025-08-05

FIGHT-210

8 enrolled 13 charts

Phase 2 Not yet recruiting

Acrocephalosyndactylia, Carcinoma, Non-Small-Cell Lung, Recurrence

NCT07097948 2025-08-01

Adjuvant

40 enrolled

Recurrence, Small Cell Lung Carcinoma

NCT05455424 2025-05-15

NERO

Other solid neoplasmThoracic

88 enrolled

Mesothelioma, Malignant, Mesothelioma, Recurrence

NCT05275673 2025-04-24

A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer

7 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Recurrence

NCT06728852 2024-12-11

Vigor

Phase 2 Recruiting

32 enrolled

Phase 2 Not yet recruiting

Lung Neoplasms, Recurrence

NCT06648200 2024-10-18

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

100 enrolled

Recurrence, Small Cell Lung Carcinoma

NCT03805841 2023-06-28

RAIN

41 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT03713944 2023-03-01

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

30 enrolled 28 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02674568 2021-07-30

TRINITY

342 enrolled 18 charts

Recurrence, Small Cell Lung Carcinoma

NCT01588821 2020-09-29

Cabozantinib in Advanced Solid Malignancies

37 enrolled 10 charts

GenitourinaryThoracic

Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT02492568 2020-08-17

PEMBRO-RT

92 enrolled

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02147990 2020-08-12

NSCLC

318 enrolled 29 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT03613753 2020-02-05

Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Phase 2 Unknown

72 enrolled

Recurrence, Small Cell Lung Carcinoma

NCT01173523 2019-04-16

Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

25 enrolled 8 charts

Recurrence, Small Cell Lung Carcinoma

NCT02623127 2019-01-23

KOSMIC

25 enrolled

Neoplasm Metastasis, Recurrence, Thymoma

NCT02166658 2018-01-23

CaBaMet

8 enrolled

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT01511081 2017-12-07

Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)

21 enrolled 5 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Recurrence, Carcinoma, Large Cell

NCT00612677 2017-03-23

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

1 enrolled 3 charts

Lung Neoplasms, Recurrence

NCT00597116 2016-10-10

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Other solid neoplasmThoracic

25 enrolled 8 charts

Mesothelioma, Recurrence

NCT01189435 2015-11-18

Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib

2 enrolled 3 charts

Lung Neoplasms, Recurrence

NCT00284154 2013-03-13

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

51 enrolled 10 charts

Lung Neoplasms, Recurrence, Carcinoma, Small Cell

NCT00824746 2013-02-26

ReGaiN

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

53 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00116610 2009-01-21

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

75 enrolled

Hypersensitivity, Recurrence, Small Cell Lung Carcinoma

NCT00095225 2008-01-29

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

122 enrolled